Spinal cord stimulator: Difference between revisions
Content deleted Content added
m Reverted edits by 106.198.14.133 (talk) (HG) (3.4.9) |
Polygnotus (talk | contribs) DuplicateReferences +{{Duplicated citations|reason=DuplicateReferences detected:<br> * https://doi.org/10.1046%2Fj.1525-1403.1999.00150.x (refs: 15, 20)<br> |date=September 2024}} |
||
| (25 intermediate revisions by 15 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|SCS TREATMENT}} |
|||
{{Duplicated citations|reason=[[User:Polygnotus/DuplicateReferences|DuplicateReferences]] detected:<br> |
|||
* https://doi.org/10.1046%2Fj.1525-1403.1999.00150.x (refs: 15, 20)<br> |
|||
|date=September 2024}} |
|||
{{Infobox medical intervention |
{{Infobox medical intervention |
||
| name = Spinal cord stimulator |
| name = Spinal cord stimulator |
||
| image = Anterior thoracic SCS.jpg |
| image = Anterior thoracic SCS.jpg |
||
| caption = Anterior view X-ray of a spinal cord stimulator (SCS) implanted in the thoracic spine |
| caption = Anterior view X-ray of a spinal cord stimulator (SCS) implanted in the thoracic spine |
||
| alt = |
| alt = |
||
| pronounce = |
| pronounce = |
||
| synonyms = |
| synonyms = |
||
| ICD10 = |
| ICD10 = |
||
| ICD9 = |
| ICD9 = |
||
| ICD9unlinked = |
| ICD9unlinked = |
||
| MeshID = |
| MeshID = |
||
| LOINC = |
| LOINC = |
||
| other_codes = |
| other_codes = |
||
| MedlinePlus = |
| MedlinePlus = |
||
| eMedicine = |
| eMedicine = |
||
}} |
}} |
||
A '''spinal cord stimulator''' ('''SCS''') or '''dorsal column stimulator''' ('''DCS''') is a type of implantable [[neuromodulation]] device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the [[spinal cord]] (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.<ref name=Uptodate>{{cite web |last1=McKenzie-Brown |first1=Anne Marie |title=Spinal cord stimulation: Placement and management |url=https://www.uptodate.com/contents/spinal-cord-stimulation-placement-and-management?source=search_result&search=spinal%20cord%20stimuator&selectedTitle=1~150 |publisher=UptoDate |date=November 1, 2016}}</ref> There are also spinal cord stimulators under research and development that could enable patients with [[spinal cord injury]] to walk again via epidural electrical stimulation (EES).<ref>{{cite news |title=Paralysed man with severed spine walks thanks to implant |url=https://www.bbc.com/news/science-environment-60258620 |access-date=10 March 2022 |work=BBC News |date=7 February 2022}}</ref><ref>{{cite journal |last1=Rowald |first1=Andreas |last2=Komi |first2=Salif |last3=Demesmaeker |first3=Robin |last4=Baaklini |first4=Edeny |last5=Hernandez-Charpak |first5=Sergio Daniel |last6=Paoles |first6=Edoardo |last7=Montanaro |first7=Hazael |last8=Cassara |first8=Antonino |last9=Becce |first9=Fabio |last10=Lloyd |first10=Bryn |last11=Newton |first11=Taylor |last12=Ravier |first12=Jimmy |last13=Kinany |first13=Nawal |last14=D’Ercole |first14=Marina |last15=Paley |first15=Aurélie |last16=Hankov |first16=Nicolas |last17=Varescon |first17=Camille |last18=McCracken |first18=Laura |last19=Vat |first19=Molywan |last20=Caban |first20=Miroslav |last21=Watrin |first21=Anne |last22=Jacquet |first22=Charlotte |last23=Bole-Feysot |first23=Léa |last24=Harte |first24=Cathal |last25=Lorach |first25=Henri |last26=Galvez |first26=Andrea |last27=Tschopp |first27=Manon |last28=Herrmann |first28=Natacha |last29=Wacker |first29=Moïra |last30=Geernaert |first30=Lionel |last31=Fodor |first31=Isabelle |last32=Radevich |first32=Valentin |last33=Van Den Keybus |first33=Katrien |last34=Eberle |first34=Grégoire |last35=Pralong |first35=Etienne |last36=Roulet |first36=Maxime |last37=Ledoux |first37=Jean-Baptiste |last38=Fornari |first38=Eleonora |last39=Mandija |first39=Stefano |last40=Mattera |first40=Loan |last41=Martuzzi |first41=Roberto |last42=Nazarian |first42=Bruno |last43=Benkler |first43=Stefan |last44=Callegari |first44=Simone |last45=Greiner |first45=Nathan |last46=Fuhrer |first46=Benjamin |last47=Froeling |first47=Martijn |last48=Buse |first48=Nik |last49=Denison |first49=Tim |last50=Buschman |first50=Rik |last51=Wende |first51=Christian |last52=Ganty |first52=Damien |last53=Bakker |first53=Jurriaan |last54=Delattre |first54=Vincent |last55=Lambert |first55=Hendrik |last56=Minassian |first56=Karen |last57=van den Berg |first57=Cornelis A. T. |last58=Kavounoudias |first58=Anne |last59=Micera |first59=Silvestro |last60=Van De Ville |first60=Dimitri |last61=Barraud |first61=Quentin |last62=Kurt |first62=Erkan |last63=Kuster |first63=Niels |last64=Neufeld |first64=Esra |last65=Capogrosso |first65=Marco |last66=Asboth |first66=Leonie |last67=Wagner |first67=Fabien B. |last68=Bloch |first68=Jocelyne |last69=Courtine |first69=Grégoire |title=Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis |url=https://www.nature.com/articles/s41591-021-01663-5 |url-access=subscription |journal=Nature Medicine |date=February 2022 |volume=28 |issue=2 |pages=260–271 |doi=10.1038/s41591-021-01663-5 |pmid=35132264 |s2cid=246651655 |language=en |issn=1546-170X}}</ref> |
|||
A '''Spinal Cord Stimulator''' (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable [[neuromodulation]] device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the [[spinal cord]] (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.<ref name=Uptodate>{{cite web |last1=McKenzie-Brown |first1=Anne Marie |title=Spinal cord stimulation: Placement and management |url=https://www.uptodate.com/contents/spinal-cord-stimulation-placement-and-management?source=search_result&search=spinal%20cord%20stimuator&selectedTitle=1~150 |publisher=UptoDate |date=November 1, 2016}}</ref> |
|||
==Medical uses== |
==Medical uses== |
||
The most common use of SCS is [[Failed back syndrome|failed back surgery syndrome]] (FBSS) in the United States and peripheral ischemic pain in Europe.<ref>{{Cite journal| |
The most common use of SCS is [[Failed back syndrome|failed back surgery syndrome]] (FBSS) in the United States and peripheral ischemic pain in Europe.<ref>{{Cite journal|last1=Eldabe|first1=Sam|last2=Kumar|first2=Krishna|last3=Buchser|first3=Eric|last4=Taylor|first4=Rod S.|date=July 2010|title=An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management|journal=Neuromodulation|volume=13|issue=3|pages=201–209|doi=10.1111/j.1525-1403.2009.00271.x|pmid=21992833|s2cid=28409527}}</ref><ref>{{Cite journal |last1=Turner |first1=J. A. |last2=Loeser |first2=J. D. |last3=Bell |first3=K. G. |date=December 1995 |title=Spinal cord stimulation for chronic low back pain: a systematic literature synthesis |journal=Neurosurgery |volume=37 |issue=6 |pages=1088–1095; discussion 1095–1096 |pmid=8584149 |doi=10.1097/00006123-199512000-00008}}</ref> |
||
As of 2014 the FDA had approved SCS as a treatment for FBSS, chronic pain, [[ |
As of 2014 the FDA had approved SCS as a treatment for FBSS, chronic pain, [[complex regional pain syndrome]], intractable angina, as well as visceral abdominal and perineal pain<ref name="Uptodate" /> and pain in the extremities from nerve damage.<ref>{{Cite journal|last1=Song|first1=Jason J.|last2=Popescu|first2=Adrian|last3=Bell|first3=Russell L.|date=May 2014|title=Present and potential use of spinal cord stimulation to control chronic pain|journal=Pain Physician|volume=17|issue=3|pages=235–246|pmid=24850105}}</ref> |
||
Once a person has had a [[psychological evaluation]] and deemed an appropriate candidate for SCS, a temporary implant is placed, called a trial, to determine the best stimulation pattern, and the person is sent home for three to ten days with an external pulse generator. If pain control and increased activity was achieved, a permanent system, with leads and a pulse generator, is placed.{{ |
Once a person has had a [[psychological evaluation]] and deemed an appropriate candidate for SCS, a temporary implant is placed, called a trial, to determine the best stimulation pattern, and the person is sent home for three to ten days with an external pulse generator. If pain control and increased activity was achieved, a permanent system, with leads and a pulse generator, is placed.<ref>{{Cite web|title=Spinal Cord Stimulation Systems and Implantation|url=https://www.aans.org/|access-date=2021-05-06|website=www.aans.org|language=en}}</ref> |
||
== Contraindications == |
== Contraindications == |
||
SCS may be contraindicated in people who have [[Coagulopathy|coagulation]] related disorders, or are on [[Anticoagulant|anticoagulant therapy.]]<ref name=Uptodate/> Other contraindications include local and systemic infection, [[pacemakers]], or those people for whom pre-surgical imaging studies show have anatomy that makes placement difficult, or if concerns arise during psychological evaluation.<ref>{{Cite journal | |
SCS may be contraindicated in people who have [[Coagulopathy|coagulation]] related disorders, or are on [[Anticoagulant|anticoagulant therapy.]]<ref name=Uptodate/> Other contraindications include local and systemic infection, [[pacemakers]], or those people for whom pre-surgical imaging studies show have anatomy that makes placement difficult, or if concerns arise during psychological evaluation.<ref>{{Cite journal |last1=Narouze |first1=Samer |last2=Benzon |first2=Honorio T. |last3=Provenzano |first3=David A. |last4=Buvanendran |first4=Asokumar |last5=De Andres |first5=José |last6=Deer |first6=Timothy R. |last7=Rauck |first7=Richard |last8=Huntoon |first8=Marc A. |date=May 2015 |title=Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain |journal=Regional Anesthesia and Pain Medicine |volume=40 |issue=3 |pages=182–212 |doi=10.1097/AAP.0000000000000223 |pmid=25899949}}</ref><ref name=":0">{{Cite journal |last1=Deer |first1=Timothy R. |last2=Mekhail |first2=Nagy |last3=Provenzano |first3=David |last4=Pope |first4=Jason |last5=Krames |first5=Elliot |last6=Leong |first6=Michael |last7=Levy |first7=Robert M. |last8=Abejon |first8=David |last9=Buchser |first9=Eric |date=August 2014 |title=The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee |journal=Neuromodulation |volume=17 |issue=6 |pages=515–550; discussion 550 |doi=10.1111/ner.12208 |pmid=25112889|s2cid=16831609 }}</ref><ref>{{Cite journal |last1=Knezevic |first1=Nebojsa N. |last2=Candido |first2=Kenneth D. |last3=Rana |first3=Shalini |last4=Knezevic |first4=Ivana |date=July 2015 |title=The Use of Spinal Cord Neuromodulation in the Management of HIV-Related Polyneuropathy |journal=Pain Physician |volume=18 |issue=4 |pages=E643–650 |pmid=26218955}}</ref> |
||
==Adverse effects and complications== |
==Adverse effects and complications== |
||
Complications with SCS range from simple easily correctable problems to devastating paralysis, nerve injury and death. In a 7-year follow-up, the overall complication rate was |
Complications with SCS range from simple easily correctable problems to devastating paralysis, nerve injury and death. In a 7-year follow-up, the overall complication rate was 5–18%. The most common complications include lead migration, lead breakage, and infection. Other complications include rotation of the pulse generator, [[haematoma]]s (subcutaneous or epidural), [[cerebrospinal fluid]] (CSF) leak, [[post dural puncture headache]], discomfort at pulse generator site, [[seroma]] and transient [[paraplegia]].<ref>{{Cite journal |last1=Hayek |first1=Salim M. |last2=Veizi |first2=Elias |last3=Hanes |first3=Michael |date=October 2015 |title=Treatment-Limiting Complications of Percutaneous Spinal Cord Stimulator Implants: A Review of Eight Years of Experience From an Academic Center Database |journal=Neuromodulation |volume=18 |issue=7 |pages=603–608; discussion 608–609 |doi=10.1111/ner.12312 |pmid=26053499|s2cid=5724152 }}</ref> |
||
Some people find the tingling sensation caused by SCS to be unpleasant. |
Some people find the tingling sensation caused by older model SCS to be unpleasant. |
||
The most common hardware related complication is lead migration, in which the implanted electrodes move from their original placement. With this complication, recapturing paraesthesia coverage can be attempted with reprogramming.<ref>{{Cite journal | |
The most common hardware related complication is lead migration, in which the implanted electrodes move from their original placement. With this complication, recapturing paraesthesia coverage can be attempted with reprogramming.<ref>{{Cite journal |last1=Eldabe |first1=Sam |last2=Buchser |first2=Eric |last3=Duarte |first3=Rui V. |date=2016-02-01 |title=Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the Literature |journal=Pain Medicine |volume=17 |issue=2 |pages=325–336 |doi=10.1093/pm/pnv025|pmid=26814260 |doi-access=free }}</ref> In circumstances involving major lead migration a reoperation may be required to reset the lead placement.<ref name=Kumar2007>{{Cite journal |last1=Kumar |first1=Krishna |last2=Buchser |first2=Eric |last3=Linderoth |first3=Bengt |last4=Meglio |first4=Mario |last5=Van Buyten |first5=Jean-Pierre |date=January 2007 |title=Avoiding complications from spinal cord stimulation: practical recommendations from an international panel of experts |journal=Neuromodulation |volume=10 |issue=1 |pages=24–33 |doi=10.1111/j.1525-1403.2007.00084.x |pmid=22151809|s2cid=24925287 }}</ref> Studies differ greatly in reporting the percentage of people who have<!--to avoid false positives in search for 'have led/lead' typo --> lead migration but the majority of studies report in the range of 10-25% of lead migration for spinal cord stimulation.<ref name=Kumar2007/> |
||
==Mechanism of action== |
==Mechanism of action== |
||
The neurophysiological mechanisms of action of spinal cord stimulation are not completely understood but may involve masking pain sensation with [[paresthesia|tingling]] by altering the pain processing of the [[central nervous system]].<ref>{{Cite journal | |
The neurophysiological mechanisms of action of spinal cord stimulation are not completely understood but may involve masking pain sensation with [[paresthesia|tingling]] by altering the pain processing of the [[central nervous system]].<ref>{{Cite journal |last1=Sinclair |first1=Chantelle |last2=Verrills |first2=Paul |last3=Barnard |first3=Adele |date=2016-07-01 |title=A review of spinal cord stimulation systems for chronic pain |journal=Journal of Pain Research |volume= 9 |pages=481–492 |doi=10.2147/jpr.s108884|pmid=27445503 |pmc=4938148 |doi-access=free }}</ref> The mechanism of analgesia when SCS is applied in [[neuropathic]] pain states may be very different from that involved in analgesia due to limb ischemia.<ref>{{Cite journal |last1=Linderoth |first1=B. |last2=Foreman |first2=R. D. |date=July 1999 |title=Physiology of spinal cord stimulation: review and update |journal=Neuromodulation |volume=2 |issue=3 |pages=150–164 |doi=10.1046/j.1525-1403.1999.00150.x |pmid=22151202|s2cid=20384118 }}</ref><ref>{{Cite journal |last1=Oakley |first1=John C. |last2=Prager |first2=Joshua P. |date=2002-11-15 |title=Spinal cord stimulation: mechanisms of action |journal=Spine |volume=27 |issue=22 |pages=2574–2583 |doi= 10.1097/00007632-200211150-00034|pmid=12435996|s2cid=30599852 }}</ref> In neuropathic pain states, experimental evidence shows that SCS alters the local neurochemistry in dorsal horn, suppressing the hyperexcitability of the neurons. Specifically, there is some evidence for increased levels of [[GABA]] release, [[serotonin]], and perhaps suppression of levels of some excitatory amino acids, including [[glutamate]] and [[aspartate]]. In the case of ischemic pain, analgesia seems to derive from restoration of the oxygen demand supply. This effect could be mediated by inhibition of the [[sympathetic system]], although [[vasodilation]] is another possibility. It is also probable that a combination of the two above mentioned mechanisms is involved.<ref name="Kunnumourath">{{cite journal |last1=Kunnumpurath |first1=Sreekumar |last2=Srinivasagopalan |first2=Ravi |last3=Vadivelu |first3=Nalini |title=Spinal cord stimulation: principles of past, present and future practice: a review |journal=Journal of Clinical Monitoring and Computing |date=1 September 2009 |volume=23 |issue=5 |pages=333–339 |doi=10.1007/s10877-009-9201-0 |pmid=19728120|s2cid=20610801 }}</ref> |
||
== Surgical |
== Surgical procedure == |
||
Spinal |
Spinal cord stimulators are placed in two different stages: a trial stage followed by a final implantation stage. First, the skin is prepped and draped utilizing sterile technique. The [[epidural space]] is accessed with loss of resistance technique using a 14-gauge [[Tuohy needle]]. The lead is fed through carefully with fluoroscopic guidance to the appropriate spinal level. This process is repeated to place another lead adjacent to the first. [[Fluoroscopy]] is used often during the procedure to identify proper placement of the SCS leads. The lead placement depends on the patient's pain location. Based on previous studies, the lead placement for patients with low back pain is typically T9 to T10. The device technician will then turn on the stimulation, typically starting at a very low frequency. The patient is prompted to describe the sensation perceived by activation of the leads, and the technician will calibrate the SCS to achieve the maximum paresthesia coverage of the patient's targeted pain area. Finally, the leads are anchored externally to reduce risk of lead migration, the site is cleaned, and a clean dressing is applied. Once the patient has recovered from the procedure, the device is once again tested and programmed.<ref>{{Cite journal|last1=Barolat|first1=G.|last2=Massaro|first2=F.|last3=He|first3=J.|last4=Zeme|first4=S.|last5=Ketcik|first5=B.|date=February 1993|title=Mapping of sensory responses to epidural stimulation of the intraspinal neural structures in man|journal=Journal of Neurosurgery|volume=78|issue=2|pages=233–239|doi=10.3171/jns.1993.78.2.0233|issn=0022-3085|pmid=8421206}}</ref> |
||
== Patient |
== Patient screening == |
||
Patients who are candidates for stimulator placement should be screened for contraindications and comorbidities. The following should be considered prior to stimulator trial:<ref name="Uptodate" /> |
Patients who are candidates for stimulator placement should be screened for contraindications and comorbidities. The following should be considered prior to stimulator trial:<ref name="Uptodate" /> |
||
| ⚫ | * Risk of bleeding – Spinal cord stimulator trial and implant have been identified as procedures with high risk of serious intraspinal bleeding, which can cause permanent neurologic damage. Appropriate planning for discontinuation and reinstitution of anti-platelet and anticoagulant medications is necessary prior to placement of a stimulator. |
||
| ⚫ | * Psychological evaluation – Depression, anxiety, somatization, and hypochondriasis are associated with worse outcomes for spinal cord stimulators. Experts recommend psychological evaluation prior to placement. A diagnosis with a psychiatric disorder is not a strict contraindication to stimulator placement. However, treatment of the disorder prior to consideration of a trial placement is indicated. |
||
| ⚫ | * Delayed placement – Stimulators may have poor efficacy if placed many years after onset of chronic pain. One review of 400 cases found a success rate of only 9% for patients with stimulator placed over 15 years after onset of pain compared with nearly 85% for patients who received stimulators within two years of pain onset.<ref name=":1" /> |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | Risk of |
||
| ⚫ | In order to assess the efficacy of the spinal cord stimulator before implantation, a trial must be performed. This trial begins with placement of temporary leads into the epidural space and connected percutaneously to an external generator. The trial typically lasts 3–7 days followed by a 2-week reprieve before SCD implantation to ensure that there is no infection from the trial.<ref name="Kumar2007" /><ref>{{Cite journal|last1=Linderoth|first1=Bengt|last2=Foreman|first2=Robert D|date=July 1999|title=Physiology of Spinal Cord Stimulation: Review and Update|journal=Neuromodulation: Technology at the Neural Interface|volume=2|issue=3|pages=150–164|doi=10.1046/j.1525-1403.1999.00150.x|pmid=22151202|s2cid=20384118|issn=1094-7159}}</ref> Successful trial is defined by at least 50% reduction in pain and 80% paresthesia overlap of the original area of pain. If a patient has sudden changes in their pain, then further investigation is needed for possible lead migration or stimulator malfunction.<ref name=":0" /> |
||
| ⚫ | Psychological evaluation – Depression, anxiety, somatization, and hypochondriasis are associated with worse outcomes for |
||
| ⚫ | Delayed placement – Stimulators may have poor efficacy if placed many years after onset of chronic pain. One review of 400 cases found a success rate of only 9% for patients with stimulator placed over 15 years after onset of pain compared with nearly 85% for patients who received stimulators within two years of pain onset.<ref name=":1" /> |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | In order to assess the efficacy of the spinal cord stimulator before implantation, a trial must be performed. This trial begins with placement of temporary leads into the epidural space and connected percutaneously to an external generator. The trial typically lasts 3–7 days followed by a 2-week reprieve before SCD implantation to ensure that there is no infection from the trial.<ref name="Kumar2007" /><ref>{{Cite journal| |
||
== History == |
== History == |
||
Electrotherapy of pain by neurostimulation began shortly after [[Ronald Melzack|Melzack]] and [[Patrick David Wall|Wall]] proposed the [[gate control theory]] in 1965. This theory proposed that nerves carrying painful peripheral stimuli and nerves carrying touch and vibratory sensation both terminate in the [[Posterior horn of spinal cord|dorsal horn]] (the gate) of spinal cord.<ref>{{Cite journal | |
Electrotherapy of pain by neurostimulation began shortly after [[Ronald Melzack|Melzack]] and [[Patrick David Wall|Wall]] proposed the [[gate control theory]] in 1965. This theory proposed that nerves carrying painful peripheral stimuli and nerves carrying touch and vibratory sensation both terminate in the [[Posterior horn of spinal cord|dorsal horn]] (the gate) of spinal cord.<ref>{{Cite journal |last1=Kirkpatrick |first1=Daniel R. |last2=McEntire |first2=Dan M. |last3=Hambsch |first3=Zakary J. |last4=Kerfeld |first4=Mitchell J. |last5=Smith |first5=Tyler A. |last6=Reisbig |first6=Mark D. |last7=Youngblood |first7=Charles F. |last8=Agrawal |first8=Devendra K. |date=December 2015 |title=Therapeutic Basis of Clinical Pain Modulation |journal=Clinical and Translational Science |volume=8 |issue=6 |pages=848–856 |doi=10.1111/cts.12282 |pmc=4641846 |pmid=25962969}}</ref> It was hypothesized that input to the latter could be manipulated to "close the gate" to the former. As an application of the gate control theory, Shealy et al.<ref>{{Cite journal |last1=Shealy |first1=C. N. |last2=Mortimer |first2=J. T. |last3=Reswick |first3=J. B. |date=July 1967 |title=Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report |journal=Anesthesia and Analgesia |volume=46 |issue=4 |pages=489–491 |pmid=4952225 |doi=10.1213/00000539-196707000-00025|s2cid=13540296 |doi-access=free }}</ref> implanted the first spinal cord stimulator device directly on the dorsal column for the treatment of chronic pain and in 1971, Shimogi and colleagues first reported the analgesic properties of epidural spinal cord stimulation. Since then this technique has undergone numerous technical and clinical developments. |
||
At this time neurostimulation for the treatment of pain is used with [[nerve]] stimulation, spinal cord stimulation, [[deep brain stimulation]], and [[motor cortex]] stimulation. |
At this time neurostimulation for the treatment of pain is used with [[nerve]] stimulation, spinal cord stimulation, [[deep brain stimulation]], and [[motor cortex]] stimulation. |
||
== Research == |
== Research == |
||
SCS has been studied in people with Parkinson's disease<ref name=PD>{{Cite journal | |
SCS has been studied in people with Parkinson's disease<ref name=PD>{{Cite journal |last1=de Andrade |first1=Emerson Magno |last2=Ghilardi |first2=Maria Gabriela |last3=Cury |first3=Rubens Gisbert |last4=Barbosa |first4=Egberto Reis |last5=Fuentes |first5=Romulo |last6=Teixeira |first6=Manoel Jacobsen |last7=Fonoff |first7=Erich Talamoni |date=January 2016 |title=Spinal cord stimulation for Parkinson's disease: a systematic review |journal=Neurosurgical Review |volume=39 |issue=1 |pages=27–35; discussion 35 |doi=10.1007/s10143-015-0651-1 |pmid=26219854|s2cid=23077459 }}</ref> and [[angina pectoris]].<ref>{{Cite journal |last1=Taylor |first1=Rod S. |last2=De Vries |first2=Jessica |last3=Buchser |first3=Eric |last4=Dejongste |first4=Mike J. L. |date=2009-03-25 |title=Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials |journal=BMC Cardiovascular Disorders |volume=9 |pages=13 |doi=10.1186/1471-2261-9-13 |pmc=2667170 |pmid=19320999 |doi-access=free }}</ref> |
||
Research on improving the devices and software has included efforts to increasing the battery life, efforts to develop [[Feedback|closed loop]] control, and combining stimulation with implanted drug delivery systems.<ref name=PD/> |
Research on improving the devices and software has included efforts to increasing the battery life, efforts to develop [[Feedback|closed loop]] control, and combining stimulation with implanted drug delivery systems.<ref name=PD/> |
||
In August 2018, The European Commission's Horizon 2020 [[Future and Emerging Technologies]] program announced a $3.5 million funding grant for the four-nation project team that is building a prototype of an implant designed to 'rewire' the spinal cord.<ref>{{Cite news|url=https://www. |
SCS is being studied to treat spinal cord injury. In August 2018, The European Commission's Horizon 2020 [[Future and Emerging Technologies]] program announced a $3.5 million funding grant for the four-nation project team that is building a prototype of an implant designed to 'rewire' the spinal cord.<ref>{{Cite news|url=https://www.healthcareitnews.com/news/european-commission-funds-35-million-develop-prototype-implant-rewires-spinal-cord|title=European Commission funds $3.5 million to develop prototype implant that rewires a spinal cord|date=2018-08-23|work=Healthcare IT News|access-date=2018-08-24}}</ref> In September 2018, [[Mayo Clinic]] and [[University of California, Los Angeles|UCLA]] reported that spinal cord stimulation supported with physical therapy can help people with paralysis to regain their ability to stand and walk with assistance.<ref>{{Cite news|url=https://www.sciencedaily.com/releases/2018/09/180924115930.htm|title=Spinal cord stimulation, physical therapy help paralyzed man stand, walk with assistance|work=ScienceDaily|access-date=2018-09-25}}</ref> In December 2019, the first double blinded, randomized controlled pivotal study in the history of spinal cord stimulation was published in ''Lancet Neurology''.<ref>Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomized, controlled trial. https://doi.org/10.1016/S1474-4422(19)30414-4</ref> |
||
In September 2018, [[Mayo Clinic]] and [[University of California, Los Angeles|UCLA]] reported that spinal cord stimulation supported with physical therapy can help people with paralysis to regain their ability to stand and walk with assistance.<ref>{{Cite news|url=https://www.sciencedaily.com/releases/2018/09/180924115930.htm|title=Spinal cord stimulation, physical therapy help paralyzed man stand, walk with assistance|work=ScienceDaily|access-date=2018-09-25}}</ref> |
|||
==See also== |
==See also== |
||
*[[Transcutaneous electrical nerve stimulation]] |
* [[Transcutaneous electrical nerve stimulation]] |
||
==References== |
==References== |
||
Latest revision as of 09:58, 18 September 2024
 | This article contains several duplicated citations. The reason given is: DuplicateReferences detected: (September 2024)
|
| Spinal cord stimulator | |
|---|---|
 Anterior view X-ray of a spinal cord stimulator (SCS) implanted in the thoracic spine |
A spinal cord stimulator (SCS) or dorsal column stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.[1] There are also spinal cord stimulators under research and development that could enable patients with spinal cord injury to walk again via epidural electrical stimulation (EES).[2][3]
Medical uses
[edit]The most common use of SCS is failed back surgery syndrome (FBSS) in the United States and peripheral ischemic pain in Europe.[4][5]
As of 2014 the FDA had approved SCS as a treatment for FBSS, chronic pain, complex regional pain syndrome, intractable angina, as well as visceral abdominal and perineal pain[1] and pain in the extremities from nerve damage.[6]
Once a person has had a psychological evaluation and deemed an appropriate candidate for SCS, a temporary implant is placed, called a trial, to determine the best stimulation pattern, and the person is sent home for three to ten days with an external pulse generator. If pain control and increased activity was achieved, a permanent system, with leads and a pulse generator, is placed.[7]
Contraindications
[edit]SCS may be contraindicated in people who have coagulation related disorders, or are on anticoagulant therapy.[1] Other contraindications include local and systemic infection, pacemakers, or those people for whom pre-surgical imaging studies show have anatomy that makes placement difficult, or if concerns arise during psychological evaluation.[8][9][10]
Adverse effects and complications
[edit]Complications with SCS range from simple easily correctable problems to devastating paralysis, nerve injury and death. In a 7-year follow-up, the overall complication rate was 5–18%. The most common complications include lead migration, lead breakage, and infection. Other complications include rotation of the pulse generator, haematomas (subcutaneous or epidural), cerebrospinal fluid (CSF) leak, post dural puncture headache, discomfort at pulse generator site, seroma and transient paraplegia.[11]
Some people find the tingling sensation caused by older model SCS to be unpleasant.
The most common hardware related complication is lead migration, in which the implanted electrodes move from their original placement. With this complication, recapturing paraesthesia coverage can be attempted with reprogramming.[12] In circumstances involving major lead migration a reoperation may be required to reset the lead placement.[13] Studies differ greatly in reporting the percentage of people who have lead migration but the majority of studies report in the range of 10-25% of lead migration for spinal cord stimulation.[13]
Mechanism of action
[edit]The neurophysiological mechanisms of action of spinal cord stimulation are not completely understood but may involve masking pain sensation with tingling by altering the pain processing of the central nervous system.[14] The mechanism of analgesia when SCS is applied in neuropathic pain states may be very different from that involved in analgesia due to limb ischemia.[15][16] In neuropathic pain states, experimental evidence shows that SCS alters the local neurochemistry in dorsal horn, suppressing the hyperexcitability of the neurons. Specifically, there is some evidence for increased levels of GABA release, serotonin, and perhaps suppression of levels of some excitatory amino acids, including glutamate and aspartate. In the case of ischemic pain, analgesia seems to derive from restoration of the oxygen demand supply. This effect could be mediated by inhibition of the sympathetic system, although vasodilation is another possibility. It is also probable that a combination of the two above mentioned mechanisms is involved.[17]
Surgical procedure
[edit]Spinal cord stimulators are placed in two different stages: a trial stage followed by a final implantation stage. First, the skin is prepped and draped utilizing sterile technique. The epidural space is accessed with loss of resistance technique using a 14-gauge Tuohy needle. The lead is fed through carefully with fluoroscopic guidance to the appropriate spinal level. This process is repeated to place another lead adjacent to the first. Fluoroscopy is used often during the procedure to identify proper placement of the SCS leads. The lead placement depends on the patient's pain location. Based on previous studies, the lead placement for patients with low back pain is typically T9 to T10. The device technician will then turn on the stimulation, typically starting at a very low frequency. The patient is prompted to describe the sensation perceived by activation of the leads, and the technician will calibrate the SCS to achieve the maximum paresthesia coverage of the patient's targeted pain area. Finally, the leads are anchored externally to reduce risk of lead migration, the site is cleaned, and a clean dressing is applied. Once the patient has recovered from the procedure, the device is once again tested and programmed.[18]
Patient screening
[edit]Patients who are candidates for stimulator placement should be screened for contraindications and comorbidities. The following should be considered prior to stimulator trial:[1]
- Risk of bleeding – Spinal cord stimulator trial and implant have been identified as procedures with high risk of serious intraspinal bleeding, which can cause permanent neurologic damage. Appropriate planning for discontinuation and reinstitution of anti-platelet and anticoagulant medications is necessary prior to placement of a stimulator.
- Psychological evaluation – Depression, anxiety, somatization, and hypochondriasis are associated with worse outcomes for spinal cord stimulators. Experts recommend psychological evaluation prior to placement. A diagnosis with a psychiatric disorder is not a strict contraindication to stimulator placement. However, treatment of the disorder prior to consideration of a trial placement is indicated.
- Delayed placement – Stimulators may have poor efficacy if placed many years after onset of chronic pain. One review of 400 cases found a success rate of only 9% for patients with stimulator placed over 15 years after onset of pain compared with nearly 85% for patients who received stimulators within two years of pain onset.[19]
- Technical difficulty – Variations in anatomy, whether congenital or acquired, may preclude successful placement in certain individuals. Imaging of the spine is necessary to guide selection of candidates for whom spine surgery is more appropriate than stimulator placement.
Trial period
[edit]In order to assess the efficacy of the spinal cord stimulator before implantation, a trial must be performed. This trial begins with placement of temporary leads into the epidural space and connected percutaneously to an external generator. The trial typically lasts 3–7 days followed by a 2-week reprieve before SCD implantation to ensure that there is no infection from the trial.[13][20] Successful trial is defined by at least 50% reduction in pain and 80% paresthesia overlap of the original area of pain. If a patient has sudden changes in their pain, then further investigation is needed for possible lead migration or stimulator malfunction.[9]
History
[edit]Electrotherapy of pain by neurostimulation began shortly after Melzack and Wall proposed the gate control theory in 1965. This theory proposed that nerves carrying painful peripheral stimuli and nerves carrying touch and vibratory sensation both terminate in the dorsal horn (the gate) of spinal cord.[21] It was hypothesized that input to the latter could be manipulated to "close the gate" to the former. As an application of the gate control theory, Shealy et al.[22] implanted the first spinal cord stimulator device directly on the dorsal column for the treatment of chronic pain and in 1971, Shimogi and colleagues first reported the analgesic properties of epidural spinal cord stimulation. Since then this technique has undergone numerous technical and clinical developments.
At this time neurostimulation for the treatment of pain is used with nerve stimulation, spinal cord stimulation, deep brain stimulation, and motor cortex stimulation.
Research
[edit]SCS has been studied in people with Parkinson's disease[23] and angina pectoris.[24]
Research on improving the devices and software has included efforts to increasing the battery life, efforts to develop closed loop control, and combining stimulation with implanted drug delivery systems.[23]
SCS is being studied to treat spinal cord injury. In August 2018, The European Commission's Horizon 2020 Future and Emerging Technologies program announced a $3.5 million funding grant for the four-nation project team that is building a prototype of an implant designed to 'rewire' the spinal cord.[25] In September 2018, Mayo Clinic and UCLA reported that spinal cord stimulation supported with physical therapy can help people with paralysis to regain their ability to stand and walk with assistance.[26] In December 2019, the first double blinded, randomized controlled pivotal study in the history of spinal cord stimulation was published in Lancet Neurology.[27]
See also
[edit]References
[edit]- ^ a b c d McKenzie-Brown, Anne Marie (November 1, 2016). "Spinal cord stimulation: Placement and management". UptoDate.
- ^ "Paralysed man with severed spine walks thanks to implant". BBC News. 7 February 2022. Retrieved 10 March 2022.
- ^ Rowald, Andreas; Komi, Salif; Demesmaeker, Robin; Baaklini, Edeny; Hernandez-Charpak, Sergio Daniel; Paoles, Edoardo; Montanaro, Hazael; Cassara, Antonino; Becce, Fabio; Lloyd, Bryn; Newton, Taylor; Ravier, Jimmy; Kinany, Nawal; D’Ercole, Marina; Paley, Aurélie; Hankov, Nicolas; Varescon, Camille; McCracken, Laura; Vat, Molywan; Caban, Miroslav; Watrin, Anne; Jacquet, Charlotte; Bole-Feysot, Léa; Harte, Cathal; Lorach, Henri; Galvez, Andrea; Tschopp, Manon; Herrmann, Natacha; Wacker, Moïra; Geernaert, Lionel; Fodor, Isabelle; Radevich, Valentin; Van Den Keybus, Katrien; Eberle, Grégoire; Pralong, Etienne; Roulet, Maxime; Ledoux, Jean-Baptiste; Fornari, Eleonora; Mandija, Stefano; Mattera, Loan; Martuzzi, Roberto; Nazarian, Bruno; Benkler, Stefan; Callegari, Simone; Greiner, Nathan; Fuhrer, Benjamin; Froeling, Martijn; Buse, Nik; Denison, Tim; Buschman, Rik; Wende, Christian; Ganty, Damien; Bakker, Jurriaan; Delattre, Vincent; Lambert, Hendrik; Minassian, Karen; van den Berg, Cornelis A. T.; Kavounoudias, Anne; Micera, Silvestro; Van De Ville, Dimitri; Barraud, Quentin; Kurt, Erkan; Kuster, Niels; Neufeld, Esra; Capogrosso, Marco; Asboth, Leonie; Wagner, Fabien B.; Bloch, Jocelyne; Courtine, Grégoire (February 2022). "Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis". Nature Medicine. 28 (2): 260–271. doi:10.1038/s41591-021-01663-5. ISSN 1546-170X. PMID 35132264. S2CID 246651655.
- ^ Eldabe, Sam; Kumar, Krishna; Buchser, Eric; Taylor, Rod S. (July 2010). "An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management". Neuromodulation. 13 (3): 201–209. doi:10.1111/j.1525-1403.2009.00271.x. PMID 21992833. S2CID 28409527.
- ^ Turner, J. A.; Loeser, J. D.; Bell, K. G. (December 1995). "Spinal cord stimulation for chronic low back pain: a systematic literature synthesis". Neurosurgery. 37 (6): 1088–1095, discussion 1095–1096. doi:10.1097/00006123-199512000-00008. PMID 8584149.
- ^ Song, Jason J.; Popescu, Adrian; Bell, Russell L. (May 2014). "Present and potential use of spinal cord stimulation to control chronic pain". Pain Physician. 17 (3): 235–246. PMID 24850105.
- ^ "Spinal Cord Stimulation Systems and Implantation". www.aans.org. Retrieved 2021-05-06.
- ^ Narouze, Samer; Benzon, Honorio T.; Provenzano, David A.; Buvanendran, Asokumar; De Andres, José; Deer, Timothy R.; Rauck, Richard; Huntoon, Marc A. (May 2015). "Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain". Regional Anesthesia and Pain Medicine. 40 (3): 182–212. doi:10.1097/AAP.0000000000000223. PMID 25899949.
- ^ a b Deer, Timothy R.; Mekhail, Nagy; Provenzano, David; Pope, Jason; Krames, Elliot; Leong, Michael; Levy, Robert M.; Abejon, David; Buchser, Eric (August 2014). "The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee". Neuromodulation. 17 (6): 515–550, discussion 550. doi:10.1111/ner.12208. PMID 25112889. S2CID 16831609.
- ^ Knezevic, Nebojsa N.; Candido, Kenneth D.; Rana, Shalini; Knezevic, Ivana (July 2015). "The Use of Spinal Cord Neuromodulation in the Management of HIV-Related Polyneuropathy". Pain Physician. 18 (4): E643–650. PMID 26218955.
- ^ Hayek, Salim M.; Veizi, Elias; Hanes, Michael (October 2015). "Treatment-Limiting Complications of Percutaneous Spinal Cord Stimulator Implants: A Review of Eight Years of Experience From an Academic Center Database". Neuromodulation. 18 (7): 603–608, discussion 608–609. doi:10.1111/ner.12312. PMID 26053499. S2CID 5724152.
- ^ Eldabe, Sam; Buchser, Eric; Duarte, Rui V. (2016-02-01). "Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the Literature". Pain Medicine. 17 (2): 325–336. doi:10.1093/pm/pnv025. PMID 26814260.
- ^ a b c Kumar, Krishna; Buchser, Eric; Linderoth, Bengt; Meglio, Mario; Van Buyten, Jean-Pierre (January 2007). "Avoiding complications from spinal cord stimulation: practical recommendations from an international panel of experts". Neuromodulation. 10 (1): 24–33. doi:10.1111/j.1525-1403.2007.00084.x. PMID 22151809. S2CID 24925287.
- ^ Sinclair, Chantelle; Verrills, Paul; Barnard, Adele (2016-07-01). "A review of spinal cord stimulation systems for chronic pain". Journal of Pain Research. 9: 481–492. doi:10.2147/jpr.s108884. PMC 4938148. PMID 27445503.
- ^ Linderoth, B.; Foreman, R. D. (July 1999). "Physiology of spinal cord stimulation: review and update". Neuromodulation. 2 (3): 150–164. doi:10.1046/j.1525-1403.1999.00150.x. PMID 22151202. S2CID 20384118.
- ^ Oakley, John C.; Prager, Joshua P. (2002-11-15). "Spinal cord stimulation: mechanisms of action". Spine. 27 (22): 2574–2583. doi:10.1097/00007632-200211150-00034. PMID 12435996. S2CID 30599852.
- ^ Kunnumpurath, Sreekumar; Srinivasagopalan, Ravi; Vadivelu, Nalini (1 September 2009). "Spinal cord stimulation: principles of past, present and future practice: a review". Journal of Clinical Monitoring and Computing. 23 (5): 333–339. doi:10.1007/s10877-009-9201-0. PMID 19728120. S2CID 20610801.
- ^ Barolat, G.; Massaro, F.; He, J.; Zeme, S.; Ketcik, B. (February 1993). "Mapping of sensory responses to epidural stimulation of the intraspinal neural structures in man". Journal of Neurosurgery. 78 (2): 233–239. doi:10.3171/jns.1993.78.2.0233. ISSN 0022-3085. PMID 8421206.
- ^ Krishna Kumar, Gary Hunter, Denny Demeria, Spinal Cord Stimulation in Treatment of Chronic Benign Pain: Challenges in Treatment Planning and Present Status, a 22-Year Experience, Neurosurgery, Volume 58, Issue 3, March 2006, Pages 481–496, https://doi.org/10.1227/01.NEU.0000192162.99567.96
- ^ Linderoth, Bengt; Foreman, Robert D (July 1999). "Physiology of Spinal Cord Stimulation: Review and Update". Neuromodulation: Technology at the Neural Interface. 2 (3): 150–164. doi:10.1046/j.1525-1403.1999.00150.x. ISSN 1094-7159. PMID 22151202. S2CID 20384118.
- ^ Kirkpatrick, Daniel R.; McEntire, Dan M.; Hambsch, Zakary J.; Kerfeld, Mitchell J.; Smith, Tyler A.; Reisbig, Mark D.; Youngblood, Charles F.; Agrawal, Devendra K. (December 2015). "Therapeutic Basis of Clinical Pain Modulation". Clinical and Translational Science. 8 (6): 848–856. doi:10.1111/cts.12282. PMC 4641846. PMID 25962969.
- ^ Shealy, C. N.; Mortimer, J. T.; Reswick, J. B. (July 1967). "Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report". Anesthesia and Analgesia. 46 (4): 489–491. doi:10.1213/00000539-196707000-00025. PMID 4952225. S2CID 13540296.
- ^ a b de Andrade, Emerson Magno; Ghilardi, Maria Gabriela; Cury, Rubens Gisbert; Barbosa, Egberto Reis; Fuentes, Romulo; Teixeira, Manoel Jacobsen; Fonoff, Erich Talamoni (January 2016). "Spinal cord stimulation for Parkinson's disease: a systematic review". Neurosurgical Review. 39 (1): 27–35, discussion 35. doi:10.1007/s10143-015-0651-1. PMID 26219854. S2CID 23077459.
- ^ Taylor, Rod S.; De Vries, Jessica; Buchser, Eric; Dejongste, Mike J. L. (2009-03-25). "Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials". BMC Cardiovascular Disorders. 9: 13. doi:10.1186/1471-2261-9-13. PMC 2667170. PMID 19320999.
- ^ "European Commission funds $3.5 million to develop prototype implant that rewires a spinal cord". Healthcare IT News. 2018-08-23. Retrieved 2018-08-24.
- ^ "Spinal cord stimulation, physical therapy help paralyzed man stand, walk with assistance". ScienceDaily. Retrieved 2018-09-25.
- ^ Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomized, controlled trial. https://doi.org/10.1016/S1474-4422(19)30414-4